Market Tracker

10/21 12:47pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.02
Real-Time Quote
 -0.13 / -1.42%
Today’s Change
6.88
Today|||52-Week Range
18.18
-39.83%
Year-to-Date

Today’s Trading

Previous close9.15
Today’s open9.26
Day’s range9.00 - 9.27
Volume493,775
Average volume (3 months)1,315,112
Market cap$1.1B
Dividend yield--
Data as of 12:31pm ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+13.68%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc-0.08-1.60%
BLUEbluebird bio Inc+0.71+1.93%
OPHTOphthotech Corp+0.19+0.49%
KITEKite Pharma Inc+1.62+4.72%
Data as of 12:46pm ET, 10/21/2014

Financials

Next reporting dateNovember 7, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts